找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Vascular Embolotherapy; A Comprehensive Appr Jafar Golzarian (Professor of Radiology, Departmen Book 2006 Springer-Verlag Berlin Heidelberg

[復(fù)制鏈接]
樓主: Menthol
11#
發(fā)表于 2025-3-23 11:13:20 | 只看該作者
12#
發(fā)表于 2025-3-23 16:15:17 | 只看該作者
Yttrium-90 Radioembolization for the Treatment of Liver Metastasesaforementioned studies representing the collective clinical experience supporting the safety and therapeutic benefit of TheraSphere and SIR-Spheres in patients with metastatic disease to the liver suggest further investigation for additional applications. Disease states where further work should be
13#
發(fā)表于 2025-3-23 18:18:23 | 只看該作者
Portal Vein Embolizationher than proximal occlusion or ligation. Embolic agents producing high local inflammatory reaction induce greater hypertrophy than others do..PVE neither improves nor worsens long-term prognosis but it allows curative resection in patients that otherwise are considered as unresectable. Nowadays, it
14#
發(fā)表于 2025-3-23 23:11:49 | 只看該作者
Embolotherapy for Neuroendocrine Tumor Hepatic Metastasesing small numbers of patients. It is unlikely that this situation will change in the near future, since prospective studies are difficult to perform in such a relatively rare and biologically heterogeneous disease. Embolotherapy is a widely accepted method of treatment for nonresectable hepatic meta
15#
發(fā)表于 2025-3-24 06:26:31 | 只看該作者
16#
發(fā)表于 2025-3-24 09:46:47 | 只看該作者
17#
發(fā)表于 2025-3-24 14:06:08 | 只看該作者
Endovenous Thermal Ablation of Incompetent Truncal Veins in Patients with Superficial Venous Insuffient SVI due to a virtual absence of the high rate of groin neovascularity seen with high ligation and stripping of the GSV. EVTA procedures have already begun to supplant traditional surgery for truncal incompetence.
18#
發(fā)表于 2025-3-24 15:00:11 | 只看該作者
19#
發(fā)表于 2025-3-24 19:28:02 | 只看該作者
20#
發(fā)表于 2025-3-25 01:14:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 10:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
高台县| 璧山县| 隆尧县| 鹤壁市| 井研县| 防城港市| 莎车县| 漳州市| 乌兰县| 丘北县| 蛟河市| 北京市| 秦安县| 福建省| 武宣县| 香港 | 郸城县| 扶绥县| 林西县| 峨眉山市| 商水县| 宜兰县| 郯城县| 榆林市| 游戏| 岗巴县| 定州市| 汾阳市| 思南县| 凤凰县| 峨眉山市| 石棉县| 吕梁市| 图们市| 苏州市| 始兴县| 深圳市| 富顺县| 休宁县| 全南县| 青田县|